McPherson ME, Anderson AR, Castillejo MI, et al. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer 2010;54:552–8.Search in Google Scholar
Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431–7.10.1182/blood.V76.7.1431.1431Search in Google Scholar
Adams RJ, Brambilla D; Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353:2769–78.10.1056/NEJMoa05046016382063Search in Google Scholar
Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5–11.10.1056/NEJM1998070233901029647873Search in Google Scholar
Casella JF, King AA, Barton B, et al. Design of the Silent Cerebral Infarct Transfusion (SIT) Trial. Pediatr Hematol Oncol 2010;27:69–89.10.3109/08880010903360367557247720201689Search in Google Scholar
Ware RE, Schultz WH, Yovetich N, et al. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatr Blood Cancer 2011;57:1011–17.10.1002/pbc.23145317164021826782Search in Google Scholar
Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37–43.10.1046/j.1537-2995.2002.00007.x11896310Search in Google Scholar
Castellino SM, Combs MR, Zimmerman SA, Issitt PD, Ware RE. Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. Br J Haematol 1999;104: 189–94.10.1046/j.1365-2141.1999.01127.x10027733Search in Google Scholar
Smith-Whitley K. Alloimmunization in patients with sickle cell disease. In: Herman JH, Manno CS, eds. Pediatric Transfusion Therapy. Bethesda, MD: AABB Press; 2003:249–82.Search in Google Scholar
Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684–90.10.1046/j.1537-2995.2002.00126.x12147019Search in Google Scholar
Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011;51:1732–9.10.1111/j.1537-2995.2010.03045.x21332724Search in Google Scholar
Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086–92.10.1046/j.1537-2995.2001.41091086.x11552063Search in Google Scholar
